Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures 
Picard / SynCardia Featured on the Cruxx of MedTech Podcast
TUCSON, Ariz., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company...
Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform
MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of...
ClinNEXUS Appoints Jovan Hollins to Chief Operating Officer
- A seasoned healthcare executive with nearly two decades of leadership experience, Mr. Jovan Hollins will lead ClinNEXUS’ operations at...
AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39
KAI 12L, the AI powering Kardia 12L, adds five new detections to further expand diagnostic capabilities for the world's first...
Dror Secures Israeli Regulatory Approval to Market and Sell Its Next Generation Smile Correction Solution
AMAR regulatory approval will allow the Company to launch ZSmile in Israel in 2026 as a precursor to a larger...
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Nu-Tek Manufacturing Facility Nu-Tek's state-of-the-art facility, purpose built to provide over 2000 metric tons of animal-free production annually. Nu-Tek BioSciences...
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
– Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials – This next-generation anthracycline demonstrates safety and promising...
Propanc Biopharma Provides Shareholder Update
CEO Highlights Significant Progress Achieved & Outlines Ambitious Plans for 2026MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma,...
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
Company Remains Fully Committed to Advancing Its Core Intranasal Medical Pipeline, alongside examining new opportunities including in fields of aviation,...
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 13, 2026...
LifeRx Formally Launches Nationwide ED & Hair Loss Treatment Programs After Strong Early Traction
Cherry Hill, NJ, Jan. 13, 2026 (GLOBE NEWSWIRE) -- LifeRx, a trusted telehealth and wellness company specializing in metabolic, hormonal,...
Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
The minimally dilutive funding will accelerate Pelthos’ highly successful commercialization efforts for its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%...
NetraMark Announces Private Placement Financing
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a...
LIS Technologies Inc. Announces Fourth Consecutive Oversubscribed Funding Round of $17 Million, Totaling $64 Million to Revitalize the Only U.S.-Origin, Patented Laser Uranium Enrichment Technology to Support the Domestic Nuclear Fuel Cycle
LIS Technologies closes 240% oversubscribed funding round of $17 Million, Totaling $64 Million.Oak Ridge, Tennessee--(Newsfile Corp. - January 13, 2026)...
Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change
BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company” or “Pheton”), a healthcare solution provider specializing...
NanoViricides Comments on the Need for Broad-Spectrum Antivirals in Light of the Current Influenza Wave – NV-387 is Effective Against H3N2
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Biofrontera Inc. Announces Record Preliminary Fourth Quarter 2025 Revenues between $17.0 Million and $17.5 Million, Representing Approximately 35% Year-Over-Year Growth
Fourth quarter results represent highest quarterly revenue in Company’s historyQ4 year-over-year growth of 35% to 39% driven by sales execution...
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
VALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound...
GridAI’s Role at the Center of Grid Intelligence Economics
BOCA RATON, FL / ACCESS Newswire / January 13, 2026 / Infrastructure narratives are easy to tell. Execution narratives are...
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focusIn future, Evaxion’s proprietary AI-Immunology™ platform...